First cloned pig is born in Piracicaba and sees the queue of SUS organs

Pesquisadores from USP celebrated the birth of a pig cloned inside São Paulo. The animal was born healthy at Piracicaba. The initiative is part of a project that seeks to make pig organs viable for humans.
The clone represents the first record of the technique in América Latina. Cientistas worked with gene editing to reduce rejection risks. The initial focus is on the kidneys, cornea, heart and skin.
Edição genetics prepares organs for human compatibility
Cientistas used the CRISPR/Cas9 tool to inactivate three pig genes responsible for activating immunological rejection. At the same time, they inserted seven human genes into the animal’s cells. The objective is to make the tissues more tolerated by the recipient organism.
The pig was born after a gestation period of almost four months in hybrid recipient females. Ele weighed 1.7 kilograms at birth. The team considers the result a milestone after around six years of research.
The project has support from Fapesp and involves Centro from Ciência to Desenvolvimento in Xenotransplante, linked to USP. Pesquisadores highlight the need for technological sovereignty. Sem national production, the country could depend on imported solutions in the future.
- Três inactivated porcine genes to avoid immediate rejection
- Sete human genes inserted for greater compatibility
- Clinical Biosafety Instalações in São Paulo for Future Creation
- Rins, cornea, heart and skin as initial priorities
- Cobertura estimated 94% of transplant demand in the SUS
Animal lives in strict biosecurity conditions
The cloned and edited pigs will be kept in highly controlled sanitary environments. Essa measure eliminates risks of transmission of swine pathogens to humans. The protocol includes full traceability and animal welfare.
The current phase is still pre-clinical. Testes in humans is pending regulatory approval and results of additional studies. Brasil already runs the largest public transplant program in the world, but faces a long waiting list.
Xenotransplante seeks to reduce external dependency
Países like Estados Unidos and China advance in clinical trials with porcine organs. No Brasil, the project aims for local production on a scale. The goal includes reducing costs and expanding access via SUS.
Pesquisadores plan to generate more edited embryos from the clone’s cells. The process allows animals with the same modified genetic profile to be multiplied. Essa strategy accelerates technology development.
The birth occurred in Instituto of Zootecnia of Agência Paulista of Tecnologia of Agronegócios, in Piracicaba. The exact due date was late March or early April. Equipes celebrated the successful cloning with applause in the laboratory.
Demanda by organs in the SUS boosts research
Milhares of Brazilians awaiting transplant today. The four prioritized organs and tissues account for the majority of procedures performed in the public system. Scientific advancement can alleviate this pressure over the years.
Cientistas avoid promises of immediate solutions. The path includes safety validation, clinical trials and regulation. Ainda thus, the clone paves the way for national production.






